Abstract: The present application relates to an encapsulant for a PV module, a method of manufacturing the same and a PV module. The encapsulant according to an embodiment of the present application has excellent heat resistance or the like and improved creep physical properties, and thus even when the encapsulant is used under conditions of a high temperature and/or high humidity for a long time, deformation is small and the encapsulant can exhibit excellent adhesive strength. Accordingly, when the encapsulant is applied to a PV module, durability or the like may be improved.

Abstract: The present invention relates to a method for forming a silicon oxide nanopattern, in which the method can be used to easily form a nanodot or nanohole-type nanopattern, and a metal nanopattern formed by using the same can be properly applied to a next-generation magnetic recording medium for storage information, etc., a method for forming a metal nanopattern, and a magnetic recording medium for information storage using the same. The method for forming a silicon oxide nanopattern includes the steps of forming a block copolymer thin film including specific hard segments and soft segments containing a (meth)acrylate-based repeating unit on silicon oxide of a substrate; conducting orientation of the thin film; selectively removing the soft segments from the block copolymer thin film; and conducting reactive ion etching of silicon oxide using the block copolymer thin film from which the soft segments are removed, as a mask to form a silicon oxide nanodot or nanohole pattern.

Abstract: A liquid crystal display includes: a first substrate and a second substrate facing each other. The first substrate includes a gate line which defines a gate electrode; a passivation layer on the gate line; a pixel in which are disposed, a pixel electrode and a common electrode which overlap each other with an insulating layer therebetween; and a first auxiliary wire and a second auxiliary wire each disposed between the passivation layer and the insulating layer, the first and second auxiliary wires extended parallel to a direction in which the gate line extends, the extended first and second auxiliary wires spaced apart from each other by a gap. The second substrate includes a column spacer.

Abstract: A liquid crystal display includes a first substrate and a second substrate facing each other; a pixel electrode disposed on the first substrate; a first alignment layer formed on at least one of the first substrate and the second substrate; a second alignment layer disposed on a same substrate as the first alignment layer, and a liquid crystal layer interposed between the first substrate and the second substrate, where the first alignment layer is a rubbing alignment layer, and the second alignment layer is a photo-alignment layer. A method of manufacturing the liquid crystal display is also provided.

Abstract: A zirconium alloy is manufactured through melting; solution heat treatment at 1,000 to 1,050° C. for 30 to 40 min and ?-quenching using water; preheating at 630 to 650° C. for 20 to 30 min and hot rolling at a reduction ratio of 60 to 65%; primary intermediate vacuum annealing at 570 to 590° C. for 3 to 4 hr and primarily cold-rolled at a reduction ratio of 30 to 40%; secondary intermediate vacuum annealing at 560 to 580° C. for 2 to 3 hr and secondarily cold-rolled at a reduction ratio of 50 to 60%; tertiary intermediate vacuum annealing at 560 to 580° C. for 2 to 3 hr and tertiarily cold-rolled at a reduction ratio of 30 to 40%; and final vacuum annealing at 440 to 650° C. for 7 to 9 hr.

Abstract: A zirconium alloy is manufactured through melting; solution heat treatment at 1,000 to 1,050° C. (?) for 30 to 40 min and ?-quenching using water; preheating at 630 to 650° C. for 20 to 30 min and hot rolling at a reduction ratio of 60 to 65%; primary intermediate vacuum annealing at 570 to 590° C. for 3 to 4 hr and primarily cold-rolled at a reduction ratio of 30 to 40%; secondary intermediate vacuum annealing at 560 to 580° C. for 2 to 3 hr and secondarily cold-rolled at a reduction ratio of 50 to 60%; tertiary intermediate vacuum annealing at 560 to 580° C. for 2 to 3 hr and tertiarily cold-rolled at a reduction ratio of 30 to 40%; and final vacuum annealing at 460 to 590° C. for 7 to 9 hr.

Abstract: Disclosed are novel indanone derivatives, pharmaceutically acceptable salts thereof or enantiomers, a preparation method thereof, and a pharmaceutical composition for the prevention or treatment of viral diseases, comprising the same as an active ingredient. The indanone derivatives have excellent inhibitory activity against picornaviruses including coxsackie-, entero-, echo-, Polio-, and rhinoviruses, as well as exhibiting low cytotoxicity, so that they can be useful as an active ingredient of a pharmaceutical composition for the prevention or treatment of viral diseases including poliomyelitis, paralysis, acute hemorrhagic conjunctivitis, viral meningitis, hand-foot-and-mouth disease, vesicular disease, hepatitis A, myositis, myocarditis, pancreatitis, diabetes, epidemic myalgia, encephalitis, cold, herpangina, foot-and-mouth disease, asthma, chronic obstructive pulmonary disease, pneumonia, sinusitis or otitis media.

Abstract: Disclosed are indanone derivatives, pharmaceutically acceptable salts thereof or enantiomers, a preparation method thereof, and a pharmaceutical composition for the prevention or treatment of viral diseases, comprising the same as an active ingredient. The indanone derivatives have excellent inhibitory activity against picornaviruses including coxsackie-, entero-, echo-, Polio-, and rhinoviruses, as well as exhibiting low cytotoxicity, so that they can be useful as an active ingredient of a pharmaceutical composition for the prevention or treatment of viral diseases including poliomyelitis, paralysis, acute hemorrhagic conjunctivitis, viral meningitis, hand-foot-and-mouth disease, vesicular disease, hepatitis A, myositis, myocarditis, pancreatitis, diabetes, epidemic myalgia, encephalitis, cold, herpangina, foot-and-mouth disease, asthma, chronic obstructive pulmonary disease, pneumonia, sinusitis or otitis media.

Abstract: Provided is a waterproof sound-permitting sheet, including: a porous nanoweb that has a plurality of pores and that is formed by electrospinning a polymer material to which a black or a different color pigment is added, thereby shortening a manufacturing process and improving waterproofing performance and sound-permitting performance.

Abstract: A light emitting module includes a light source board having a first surface and a second surface opposing the first surface and extending from one end to the other end, forming a spiral shape; at least one light source disposed on the first surface of the light source board; and a heat dissipation plate disposed on the second surface of the light source board and provided with a contact surface having a spiral shape corresponding to that of the light source board.

Abstract: Provided is a diaphragm for use in a speaker that is configured to include a nanoweb that is formed by electrospinning a polymer material and accumulating nanofibers, so as to have a plurality of pores through which air can pass. The diaphragm can be made thin, have excellent flexibility, have sufficient strength to endure sound pressure, and enhance sound quality of low pitched bands.

Abstract: A battery module includes a plurality of rechargeable batteries, end plates at outer sides of the rechargeable batteries; fixing members fixed to the end plates, each fixing member having a support step protruding from at least one side end, a reinforcement member contacting the fixing member, and a fastener fixing the fixing member and the reinforcement member to the end plate.

Abstract: Disclosed are 1,3-Dioxoindene derivatives, pharmaceutically acceptable salts thereof or enantiomers, a preparation method thereof, and a pharmaceutical composition for the prevention or treatment of viral diseases, comprising the same as an active ingredient. The 1,3-Dioxoindene derivatives have excellent inhibitory activity against picornaviruses including coxsackie-, entero-, echo-, Polio-, and rhinoviruses, as well as exhibiting low cytotoxicity, so that they can be useful as an active ingredient of a pharmaceutical composition for the prevention or treatment of viral diseases including poliomyelitis, paralysis, acute hemorrhagic conjunctivitis, viral meningitis, hand-foot-and-mouth disease, vesicular disease, hapatitis A, myositis, myocarditis, pancreatitis, diabetes, epidemic myalgia, encephalitis, cold, herpangina, foot-and-mouth disease, asthma, chronic obstructive pulmonary disease, pneumonia, sinusitis or otitis media.

Abstract: An air conditioning system and a controlling method of the same are provided.

Abstract: A test board unit may include a test board, a thermal tank and a heat-dissipating plate. The test board may be configured to provide a semiconductor chip with a test current. The thermal tank may be configured to dissipate heat generated in the semiconductor chip. The heat-dissipating plate may be coupled between the test board and the thermal tank and may be configured to transfer the heat from the semiconductor chip to the thermal tank.

Abstract: A display apparatus includes a timing controller for converting data values of black image signals to have one polarity with respect to a common voltage and for converting data values of low gray scale image signals to have one polarity with respect to the common voltage, a data driver for converting the image signals outputted from the timing controller into data voltages, and a plurality of pixels for receiving the data voltages in response to gate signals to display an image.

Abstract: An integrated circuit includes first to third failure information storage units, an input selection unit suitable for alternately storing plural pieces of failure information in the first and second failure information storage units generated whenever each of a plurality of tests is performed on a device under test (DUT), and a storage selection unit suitable for relocating the plural pieces of failure information from the first or second failure information storage unit that was not selected by the input selection unit, to the third failure information storage unit while excluding overlapping failure information from relocating.

Abstract: Disclosed are a compound for an organic optoelectronic device, an organic light emitting diode including the same, and a display device including the organic light emitting diode. A compound for an organic optoelectronic device represented by Chemical Formula 1 provides an organic optoelectronic device having an excellent life-span and improved luminous efficiency at a low driving voltage due to excellent electrochemical and thermal stability.

Abstract: The present invention relates to a pharmaceutical composition containing a monoacetyldiacylglycerol compound as an active ingredient for preventing or treating asthma, and a functional health food composition for preventing or treating asthma. The monoacetyldiacylglycerol compound of the present invention inhibits the expression of IL-4 in EL-4 cells, which are mouse T cell lymphoma cells, reduces hypersensitivity of airway in an asthma-induced animal model, and inhibits the infiltration of inflammatory cells into the bronchial tube. In addition, the compounds of the present invention inhibit the generation of IgE in the serum and bronchoalveolar lavage fluid, have an excellent effect of inhibiting the expression of Th2 cytokines (IL-4, IL-5, and IL-13) in the lung, thereby overcome side effects of the currently used therapeutic agents for asthma, have no toxicity, and exhibit a superior therapeutic effect, and thus can be useful as a composition for preventing, treating, and alleviating asthma.

Abstract: A nanotransfer printing method, including the steps of coating a polymer thin film on a template substrate where a surface pattern is formed, fabricating the polymer thin film into a thin-film replica mold by using the polymer thin film and an adhesive film, forming nanostructures on the thin-film replica mold, selectively weakening an adhesive force between the adhesive film and the thin-film replica mold, and transferring the nanostructures into a target object, is provided.